{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:58:36Z","timestamp":1694624316427},"reference-count":16,"publisher":"EDITORA SCIENTIFIC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Bras. Psiquiatr."],"published-print":{"date-parts":[[2003,6]]},"abstract":"<jats:p>\u00c9 vasta a literatura demonstrando a efic\u00e1cia dos antidepressivos inibidores seletivos da recapta\u00e7\u00e3o de serotonina na Bulimia Nervosa, diminuindo a freq\u00fc\u00eancia do comportamento alimentar compulsivo e dos v\u00f4mitos. A boa resposta terap\u00eautica aos agentes farmacol\u00f3gicos noradren\u00e9rgicos, como a desipramina e a reboxetina, embora menos encontrada na literatura, tamb\u00e9m j\u00e1 foi documentada. O presente relato de caso descreve o tratamento de uma paciente com Bulimia Nervosa utilizando-se reboxetina na dose de 4 a 8 mg ao dia. A resposta terap\u00eautica vem confirmar os resultados favor\u00e1veis do uso desta droga no tratamento da Bulimia Nervosa.<\/jats:p>","DOI":"10.1590\/s1516-44462003000200010","type":"journal-article","created":{"date-parts":[[2005,4,26]],"date-time":"2005-04-26T16:17:33Z","timestamp":1114532253000},"page":"100-102","source":"Crossref","is-referenced-by-count":1,"title":["Reboxetina no tratamento da bulimia nervosa"],"prefix":"10.47626","volume":"25","author":[{"given":"Simone Mancini","family":"Castilho","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Henrique Viegas","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27448","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1176\/ajp.146.8.963","article-title":"Neurochemical abnormalities of anorexia nervosa and bulimia nervosa","volume":"146","author":"Fava M","year":"1989","journal-title":"Am J Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0006-3223(89)90151-0","article-title":"Neuroendocrine profile in bulimia nervosa","volume":"25","author":"Levy B","year":"1989","journal-title":"Biol Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0006-3223","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0006-3223(92)90026-V","article-title":"The effect of a mental challenge test of plasma norepinephrine and cortisol in bulimia nervosa and in controls","volume":"32","author":"Pirke K","year":"1992","journal-title":"Biol Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0006-3223","issn-type":"print"},{"issue":"Suppl 3","key":"ref4","first-page":"22","article-title":"The role of serotonin in eating disorders","volume":"39","author":"Leibowitz S","year":"1990","journal-title":"Drugs","ISSN":"http:\/\/id.crossref.org\/issn\/0012-6667","issn-type":"print"},{"key":"ref5","first-page":"139","article-title":"Nervosa Collaborate Study Group. Fluoxetine in the treatment of bulimia nervosa","volume":"49","author":"Fluoxetine Bulimia","year":"1992","journal-title":"Arch Gen Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1192\/bjp.166.5.660","article-title":"For the Fluoxetine Bulimia Nervosa Research Group. Long-term fluoxetine treatment of bulimia nervosa","volume":"166","author":"Goldstein D","year":"1995","journal-title":"Br J Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0007-1250","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1176\/ajp.148.9.1206","article-title":"Long-term outcome of antidepressant treatment for bulimia nervosa","volume":"148","author":"Walsh T","year":"1991","journal-title":"Am J Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00004850-200015060-00006","article-title":"Reboxetine in the treatment of bulimia nervosa: a report of seven cases","volume":"15","author":"El-Giamal N","year":"2000","journal-title":"Int Clin Psychopharmacol","ISSN":"http:\/\/id.crossref.org\/issn\/0268-1315","issn-type":"print"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4088\/JCP.v63n0909","article-title":"Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients","volume":"63","author":"Malhotra S","year":"2002","journal-title":"J Clin Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/ajp.147.2.225","article-title":"CSF monoamine levels in normal weight bulimia: evidence for abnormal noradrenergic activity","volume":"147","author":"Kaye W","year":"1990","journal-title":"Am J Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0165-1781(96)02982-4","article-title":"Central and peripheral noradrenalin regulation in eating disorders","volume":"62","author":"Pirke K M.","year":"1996","journal-title":"Psychiatry Res","ISSN":"http:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref12","first-page":"122","article-title":"The selective norepinephrine reuptake inhibitor, LY368975, reduces comsuption in animal models of feeding","volume":"287","author":"Gehlert D","year":"1998","journal-title":"JPET"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/1098-108X(198701)6:1<29::AID-EAT2260060105>3.0.CO;2-2","article-title":"Imipramine in the treatment of bulimia: a double-blind controlled study","volume":"6","author":"Agras W","year":"1987","journal-title":"Int J Eating Disord"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/070674378803300211","article-title":"Treatment of bulimia with desipramine: a double-blind crossover study","volume":"33","author":"Barlow J","year":"1988","journal-title":"Can J Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0706-7437","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004714-198808000-00005","article-title":"Treatment of bulimia with fenfluramine and desipramine","volume":"8","author":"Blouin A","year":"1988","journal-title":"J Clin Psychopharmacol","ISSN":"http:\/\/id.crossref.org\/issn\/0271-0749","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archpsyc.1986.01800020092012","article-title":"Treating bulimia with desipramine","volume":"43","author":"Hughes P","year":"1986","journal-title":"Arch Gen Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"}],"container-title":["Revista Brasileira de Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rbp\/v25n2\/v25n02a10.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T16:11:08Z","timestamp":1654531868000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-44462003000200010&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S1516-44462003000200010"],"URL":"https:\/\/doi.org\/10.1590\/s1516-44462003000200010","relation":{},"ISSN":["1516-4446"],"issn-type":[{"value":"1516-4446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}